A new study published in The Lancet Microbe reports the first twice-yearly injectable HIV treatment regimen—combining lenacapavir, teropavimab, and zinlirvimab—has achieved high rates of viral ...

Single-pill treatment proves as effective at suppressing virus as multi-pill therapy, while long-acting preventive injections ...

Three experimental injectable antiretrovirals – a novel capsid inhibitor and two next-generation integrase inhibitors – could ...

Although HIV infection remains a global public health challenge, ART has transformed it from a fatal illness to a manageable ...

Women living with HIV/AIDS can now have safe and healthy pregnancies with early diagnosis, proper treatment, and consistent ...

Modern HIV treatment is one of medicine's great success stories. With today's therapies, many people living with HIV can ...

Merck said a treatment it is developing for HIV-1 met its primary endpoint in three Phase 3 trials. The biopharmaceutical company said Wednesday the results add to growing evidence for ...

A large international clinical trial has unveiled a promising new option for people living with highly treatment-resistant ...

A Q&A With Shauna Applin, ARNP. AJMC: Despite substantial therapeutic advances since the 1980s, the US is not on pace to achieve the goals of the Ending the HIV Epidemic (EHE) public health initiative ...

Since the HIV epidemic began, the diagnosis of HIV has evolved from a death sentence to a chronic, but manageable condition by starting and staying on treatment. HIV treatment can help people live ...

Nearly 20 states are moving to restrict assistance programs that help people afford HIV medications and treatment.

Citing rising costs and shortfalls in federal support, about 20 states are toughening eligibility requirements for patients in drug assistance programs.